Revolutionizing Treatment: uniQure’s Etranacogene Dezaparvovec Gene Therapy Receives Positive CHMP Opinion for Adults with Hemophilia B
uniQure announces positive CHMP opinion for etranacogene dezaparvovec – gene therapy for adults with hemophilia B Exciting News in the Field of Gene Therapy It’s always heartwarming to hear about advancements in medical technology that can potentially change the lives of those suffering from serious medical conditions. The recent announcement from uniQure N.V. about the…